 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
- | KTH-222 / Kalos Therap, Oncology Pharma, gemcitabine / Generic mfg.
Journal: A novel, small peptide with activity against human pancreatic cancer. (Pubmed Central) - Jun 9, 2020
Furthermore, KTH-222 does not decrease the rate of weight gain in the treated mice, suggesting the absence of gross toxicity. These activities of KTH-222 suggest that it may be useful in the treatment of pancreatic cancer.